Search Results

There are 7754112 results for: content related to: Controlling Newly Diagnosed Type 2 Diabetes Mellitus with Metformin Managed Pain Symptoms in a Patient Affected with Dercum's Disease

  1. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Shelley R Salpeter, Elizabeth Greyber, Gary A Pasternak and Edwin E Salpeter

    Published Online : 14 APR 2010, DOI: 10.1002/14651858.CD002967.pub4

  2. You have free access to this content
    Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Cα-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1

    British Journal of Pharmacology

    Volume 160, Issue 5, July 2010, Pages: 1195–1211, Yong P Hwang and Hye G Jeong

    Version of Record online : 22 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00762.x

  3. You have free access to this content
    Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis

    British Journal of Pharmacology

    Volume 166, Issue 3, June 2012, Pages: 1183–1191, K Toyama, A Yonezawa, S Masuda, R Osawa, M Hosokawa, S Fujimoto, N Inagaki, K Inui and T Katsura

    Version of Record online : 8 MAY 2012, DOI: 10.1111/j.1476-5381.2012.01853.x

  4. You have free access to this content
    Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 6, June 2009, Pages: 611–622, M. Jadzinsky, A. Pfützner, E. Paz-Pacheco, Z. Xu, E. Allen, R. Chen and CV181-039 Investigators

    Version of Record online : 6 MAY 2009, DOI: 10.1111/j.1463-1326.2009.01056.x

    Corrected by:


    Vol. 12, Issue 5, 462, Version of Record online: 30 MAR 2010

  5. Metformin in Noninsulin-Dependent Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 16, Issue 3, May-June 1996, Pages: 327–351, Audrey Jade Lee

    Version of Record online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1996.tb02964.x

  6. You have free access to this content
    Radical-induced oxidation of metformin

    European Journal of Biochemistry

    Volume 271, Issue 23-24, December 2004, Pages: 4745–4752, H. Khouri, F. Collin, D. Bonnefont-Rousselot, A. Legrand, D. Jore and M. Gardès-Albert

    Version of Record online : 2 DEC 2004, DOI: 10.1111/j.1432-1033.2004.04438.x

  7. You have free access to this content
    Involvement of carnitine/organic cation transporter OCTN1/SLC22A4 in gastrointestinal absorption of metformin

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 9, September 2013, Pages: 3407–3417, Noritaka Nakamichi, Hiroyo Shima, Satoshi Asano, Takahiro Ishimoto, Tomoko Sugiura, Kazuki Matsubara, Hiroyuki Kusuhara, Yuichi Sugiyama, Yoshimichi Sai, Ken-Ichi Miyamoto, Akira Tsuji and Yukio Kato

    Version of Record online : 10 MAY 2013, DOI: 10.1002/jps.23595

  8. Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitus

    Diabetic Medicine

    Volume 29, Issue 8, August 2012, Pages: e205–e210, S. K. Thondam, A. Cross, D. J. Cuthbertson, J. P. Wilding and C. Daousi

    Version of Record online : 15 JUL 2012, DOI: 10.1111/j.1464-5491.2012.03675.x

  9. You have free access to this content
    Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions

    British Journal of Pharmacology

    Volume 171, Issue 9, May 2014, Pages: 2351–2363, Sanna-Mari Aatsinki, Marcin Buler, Henriikka Salomäki, Markku Koulu, Petr Pavek and Jukka Hakkola

    Version of Record online : 11 APR 2014, DOI: 10.1111/bph.12585

  10. Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin

    Diabetes, Obesity and Metabolism

    Volume 5, Issue 6, November 2003, Pages: 424–431, L. Blonde, J. Wogen, C. Kreilick and A. A. Seymour

    Version of Record online : 6 NOV 2003, DOI: 10.1046/j.1463-1326.2003.00297.x

  11. You have full text access to this OnlineOpen article
    Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer

    Cancer Medicine

    Volume 4, Issue 2, February 2015, Pages: 161–173, Kevin M. Schuler, Brooke S. Rambally, Megan J. DiFurio, Brante P. Sampey, Paola A. Gehrig, Liza Makowski and Victoria L. Bae-Jump

    Version of Record online : 21 NOV 2014, DOI: 10.1002/cam4.353

  12. Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 6, December 2010, Pages: 801–808, E M Migoya, R Bergeron, J L Miller, R N K Snyder, M Tanen, D Hilliard, B Weiss, P Larson, M Gutierrez, G Jiang, F Liu, K A Pryor, J Yao, L Zhu, J J Holst, C Deacon, G Herman, N Thornberry, J Amatruda, D Williams-Herman, J A Wagner and R SinhaRoy

    Version of Record online : 3 NOV 2010, DOI: 10.1038/clpt.2010.184

  13. Adding saxagliptin to extended-release metformin vs. uptitrating metformin dosage

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 4, April 2012, Pages: 365–371, V. Fonseca, T. Zhu, C. Karyekar and B. Hirshberg

    Version of Record online : 18 JAN 2012, DOI: 10.1111/j.1463-1326.2011.01553.x

  14. Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS)

    Clinical Endocrinology

    Volume 70, Issue 1, January 2009, Pages: 124–128, Thozhukat Sathyapalan, Li Wei Cho, Eric S. Kilpatrick, Anne-Marie Coady and Stephen L. Atkin

    Version of Record online : 20 AUG 2008, DOI: 10.1111/j.1365-2265.2008.03345.x

  15. Use of metformin in pediatric age

    Pediatric Diabetes

    Volume 12, Issue 6, September 2011, Pages: 580–588, Claudia Brufani, Danilo Fintini, Valerio Nobili, Patrizia Ippolita Patera, Marco Cappa and Mario Brufani

    Version of Record online : 3 MAR 2011, DOI: 10.1111/j.1399-5448.2010.00741.x

  16. In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma

    Hepatology Research

    Volume 42, Issue 9, September 2012, Pages: 922–933, Zhan Qu, Yangde Zhang, Mingmei Liao, Yuxiang Chen, Jinfeng Zhao and Yifeng Pan

    Version of Record online : 23 APR 2012, DOI: 10.1111/j.1872-034X.2012.01007.x

  17. You have full text access to this Open Access content
    Metformin suppresses intestinal polyp growth in ApcMin/+ mice

    Cancer Science

    Volume 99, Issue 11, November 2008, Pages: 2136–2141, Ayako Tomimoto, Hiroki Endo, Michiko Sugiyama, Toshio Fujisawa, Kunihiro Hosono, Hirokazu Takahashi, Noriko Nakajima, Yoji Nagashima, Koichiro Wada, Hitoshi Nakagama and Atsushi Nakajima

    Version of Record online : 18 SEP 2008, DOI: 10.1111/j.1349-7006.2008.00933.x

  18. Lactic acidosis in metformin therapy: searching for a link with metformin in reports of ‘metformin-associated lactic acidosis’

    Diabetes, Obesity and Metabolism

    Volume 3, Issue 3, June 2001, Pages: 195–201, J. D. Lalau and J. M. Race

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1463-1326.2001.00128.x

  19. You have free access to this content
    Pharmacokinetic interaction between itraconazole and metformin in rats: competitive inhibition of metabolism of each drug by each other via hepatic and intestinal CYP3A1/2

    British Journal of Pharmacology

    Volume 161, Issue 4, October 2010, Pages: 815–829, YH Choi, U Lee, BK Lee and MG Lee

    Version of Record online : 9 JUN 2010, DOI: 10.1111/j.1476-5381.2010.00913.x

  20. Efficacy, dose–response relationship and safety of once-daily extended-release metformin (Glucophage® XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studies

    Diabetes, Obesity and Metabolism

    Volume 7, Issue 1, January 2005, Pages: 28–39, K. Fujioka, R. L. Brazg, I. Raz, S. Bruce, S. Joyal, R. Swanink and M. Pans

    Version of Record online : 10 NOV 2004, DOI: 10.1111/j.1463-1326.2004.00369.x